VOQP — Vioquest Pharmaceuticals Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Vioquest Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2003 December 31st | 2004 December 31st | R2005 December 31st | 2006 December 31st | 2007 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB/A | 10KSB/A | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.669 | 1.49 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0.473 | 0.647 | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.7 | 5.55 | 10.4 | 5.28 | 9.74 |
Operating Profit | -2.03 | -4.06 | -10.4 | -5.28 | -9.74 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.02 | -4.03 | -10.4 | -5.17 | -10.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.02 | -4.03 | -10.4 | -5.17 | -10.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.02 | -4.03 | -12.8 | -8.27 | -10.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2.02 | -4.03 | -12.8 | -8.27 | -10.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.62 | -2.35 | -1.08 | -1.3 | -2.07 |
Dividends per Share |